Angioplasty and stents treat renal arteries:
This article was originally published in Clinica
Endovascular treatments are as effective as bypass for renovascular hypertension but can be performed at a lower cost, US researchers report in the August edition of Radiology. In a retrospective analysis of 130 patients, researchers at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, found that stenting had the highest success rate at 98%, while angioplasty and bypass both exceeded 90%. However, bypassing cost $15,393 versus $1,402 for angioplasty and $2,573 for stenting. Complication rates were 13%, 16% and 38% for angioplasty, stenting and bypass respectively.
You may also be interested in...
With its US/Mexico Phase III trial delayed due to manufacturing questions, Novavax has aligned its UK study with FDA guidance. It hopes for interim data from that study during Q1 2021.
The companies think they can build out the indications for zuranalone and SAGE-324 faster and more broadly and commercialize the drugs more effectively as partners.